Deb S - Search Results

1

p53: its mutations and their impact on transcription.

Vaughan C, Pearsall I, Yeudall A, Deb SP, Deb S. Vaughan C, et al. Among authors: deb s, deb sp. Subcell Biochem. 2014;85:71-90. doi: 10.1007/978-94-017-9211-0_4. Subcell Biochem. 2014. PMID: 25201189 Review.

2

p53 mutants induce transcription of NF-κB2 in H1299 cells through CBP and STAT binding on the NF-κB2 promoter and gain of function activity.

Vaughan CA, Singh S, Windle B, Sankala HM, Graves PR, Andrew Yeudall W, Deb SP, Deb S. Vaughan CA, et al. Among authors: deb s, deb sp. Arch Biochem Biophys. 2012 Feb 1;518(1):79-88. doi: 10.1016/j.abb.2011.12.006. Epub 2011 Dec 16. Arch Biochem Biophys. 2012. PMID: 22198284 Free PMC article.

3

Allele specific gain-of-function activity of p53 mutants in lung cancer cells.

Vaughan CA, Frum R, Pearsall I, Singh S, Windle B, Yeudall A, Deb SP, Deb S. Vaughan CA, et al. Among authors: deb s, deb sp. Biochem Biophys Res Commun. 2012 Nov 9;428(1):6-10. doi: 10.1016/j.bbrc.2012.09.029. Epub 2012 Sep 16. Biochem Biophys Res Commun. 2012. PMID: 22989750 Free PMC article.

4

Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites.

Vaughan CA, Deb SP, Deb S, Windle B. Vaughan CA, et al. Among authors: deb s, deb sp. Oncotarget. 2014 Jan 30;5(2):417-27. doi: 10.18632/oncotarget.1708. Oncotarget. 2014. PMID: 24481480 Free PMC article.

5

Addiction of lung cancer cells to GOF p53 is promoted by up-regulation of epidermal growth factor receptor through multiple contacts with p53 transactivation domain and promoter.

Vaughan CA, Pearsall I, Singh S, Windle B, Deb SP, Grossman SR, Yeudall WA, Deb S. Vaughan CA, et al. Among authors: deb s, deb sp. Oncotarget. 2016 Mar 15;7(11):12426-46. doi: 10.18632/oncotarget.6998. Oncotarget. 2016. PMID: 26820293 Free PMC article.

6

MDM2 overexpression, activation of signaling networks, and cell proliferation.

Deb SP, Singh S, Deb S. Deb SP, et al. Among authors: deb s. Subcell Biochem. 2014;85:215-34. doi: 10.1007/978-94-017-9211-0_12. Subcell Biochem. 2014. PMID: 25201197 Review.

7

Lung cancer stem cells, p53 mutations and MDM2.

Gadepalli VS, Deb SP, Deb S, Rao RR. Gadepalli VS, et al. Among authors: deb s, deb sp. Subcell Biochem. 2014;85:359-70. doi: 10.1007/978-94-017-9211-0_19. Subcell Biochem. 2014. PMID: 25201204 Review.

8

Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells.

Vaughan CA, Singh S, Grossman SR, Windle B, Deb SP, Deb S. Vaughan CA, et al. Among authors: deb s, deb sp. Mol Oncol. 2017 Jun;11(6):696-711. doi: 10.1002/1878-0261.12068. Epub 2017 May 8. Mol Oncol. 2017. PMID: 28423230 Free PMC article.

9

Tumor-derived p53 mutants induce NF-kappaB2 gene expression.

Scian MJ, Stagliano KE, Anderson MA, Hassan S, Bowman M, Miles MF, Deb SP, Deb S. Scian MJ, et al. Among authors: deb s, deb sp. Mol Cell Biol. 2005 Nov;25(22):10097-110. doi: 10.1128/MCB.25.22.10097-10110.2005. Mol Cell Biol. 2005. PMID: 16260623 Free PMC article.

10

Human oncoprotein MDM2 activates the Akt signaling pathway through an interaction with the repressor element-1 silencing transcription factor conferring a survival advantage to cancer cells.

Singh S, Ramamoorthy M, Vaughan C, Yeudall WA, Deb S, Palit Deb S. Singh S, et al. Among authors: deb s. Cell Death Differ. 2013 Apr;20(4):558-66. doi: 10.1038/cdd.2012.153. Epub 2012 Dec 14. Cell Death Differ. 2013. PMID: 23238568 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,067 results

Search Page

Filters